Yesterday’s announcement was not the biggest deal, IMO. This was never a regulatory risk play.
I don’t think the price will motor until they get some success with insurers. Direct to consumer is a big market but it’s going to take a long time. At 8-10c it was very cheap, but at 18c on hot money I’d prefer to wait for further evidence.
Adherium receives US FDA 510k OTC clearance, page-27
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 288622 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 293516 | 1 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable